Abstract
Purpose
To investigate the effect of steatosis on liver signal and enhancement in multiphasic contrast-enhanced (MCE) MRI.
Materials and methods
In this IRB-approved, HIPAA-compliant, retrospective, observational study, 1217 MCE abdominal MRIs performed during 2014 at a single institution were reviewed. Of these, 1085 were excluded, due to potential factors other than steatosis that may affect liver signal intensity and/or enhancement. In the remaining 132, liver fat fraction (FF) was calculated from the in- and opposed-phase 2D T1-weighted images. Liver signal intensity, absolute enhancement, and relative enhancement on fat-suppressed (Dixon method) 3D T1-weighted images before and after injection of gadobutrol (arterial, portal venous, and equilibrium phases) were plotted against co-localized FF values and the linear trend was evaluated by Pearson correlation coefficient (r). P values <0.05 were considered statistically significant.
Results
Liver signal intensity negatively correlated with FF for all phases (r = −0.388 to −0.544, p < 0.001). Absolute enhancement negatively correlated with FF for the portal venous and equilibrium phases (r = −0.286 and −0.289, respectively, p < 0.001), but not for the arterial phase (r = −0.042, p = 0.632). Relative enhancement did not significantly correlate with FF for any phase (p ≥ 0.125).
Conclusion
Steatosis reduces liver signal intensity in MCE MRI. This effect of steatosis was reduced in calculated absolute enhancement and eliminated in calculated relative enhancement.
Similar content being viewed by others
References
American College of Radiology Liver Imaging Reporting and Data System version 2014. American College of Radiology. http://www.acr.org/Quality-Safety/Resources/LIRADS. Accessed 08/09/2015
Szczepaniak LS, Nurenberg P, Leonard D, et al. (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288(2):E462–E468. doi:10.1152/ajpendo.00064.2004
Browning JD, Szczepaniak LS, Dobbins R, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40(6):1387–1395. doi:10.1002/hep.20466
Onishi H, Theisen D, Dietrich O, Reiser MF, Zech CJ (2014) Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging. J Magn Reson Imaging 39(1):42–50. doi:10.1002/jmri.24136
Cowin GJ, Jonsson JR, Bauer JD, et al. (2008) Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 28(4):937–945. doi:10.1002/jmri.21542
Reeder SB, Sirlin CB (2010) Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am 18(3):337–357 (ix). doi:10.1016/j.mric.2010.08.013
Mashhood A, Railkar R, Yokoo T, et al. (2013) Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. J Magn Reson Imaging 37(6):1359–1370. doi:10.1002/jmri.23928
Matoori S, Froehlich JM, Breitenstein S, et al. (2015) Age dependence of spleen- and muscle-corrected hepatic signal enhancement on hepatobiliary phase gadoxetate MRI. Eur Radiol. doi:10.1007/s00330-015-3965-z
Kukuk GM, Schaefer SG, Fimmers R, et al. (2014) Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests. Eur Radiol 24(10):2482–2490. doi:10.1007/s00330-014-3291-x
Bashir MR, Breault SR, Braun R, et al. (2014) Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI. Acad Radiol 21(6):726–732. doi:10.1016/j.acra.2014.02.005
Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6(2):65–70
Browning JD, Kumar KS, Saboorian MH, Thiele DL (2004) Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 99(2):292–298
Poonawala A, Nair SP, Thuluvath PJ (2000) Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 32(4 Pt 1):689–692. doi:10.1053/jhep.2000.17894
Caldwell SH, Crespo DM (2004) The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 40(4):578–584. doi:10.1016/j.jhep.2004.02.013
Caldwell SH, Oelsner DH, Iezzoni JC, et al. (1999) Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29(3):664–669. doi:10.1002/hep.510290347
Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R (2015) Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol 13:643–654. doi:10.1016/j.cgh.2014.04.014. e641–649 quiz e639–640
Ruhl CE, Everhart JE (2015) Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 41(1):65–76. doi:10.1111/apt.13012
Seifalian AM, Piasecki C, Agarwal A, Davidson BR (1999) The effect of graded steatosis on flow in the hepatic parenchymal microcirculation. Transplantation 68(6):780–784
Yokoo T, Shiehmorteza M, Hamilton G, et al. (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258(3):749–759. doi:10.1148/radiol.10100659
Westphalen AC, Qayyum A, Yeh BM, et al. (2007) Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 242(2):450–455. doi:10.1148/radiol.2422052024
Cassidy FH, Yokoo T, Aganovic L, et al. (2009) Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 29(1):231–260. doi:10.1148/rg.291075123
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pirasteh, A., Clark, H.R., Sorra, E.A. et al. Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging. Abdom Radiol 41, 1744–1750 (2016). https://doi.org/10.1007/s00261-016-0736-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-016-0736-5